1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Breast cancer

Henlius (pertuzumab biosimilar) for treating HER2-positive breast cancer [TS ID 12094]

Topic selection

  • Project information
  • Project documents

36177-Pertuzumab-Biosimilar-for-Breast-Cancer-V1.0-JUL2024-NON-CONF.pdf (nihr.ac.uk)